Correlation Between Lidds AB and Newbury Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lidds AB and Newbury Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lidds AB and Newbury Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lidds AB and Newbury Pharmaceuticals AB, you can compare the effects of market volatilities on Lidds AB and Newbury Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lidds AB with a short position of Newbury Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lidds AB and Newbury Pharmaceuticals.

Diversification Opportunities for Lidds AB and Newbury Pharmaceuticals

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Lidds and Newbury is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Lidds AB and Newbury Pharmaceuticals AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Newbury Pharmaceuticals and Lidds AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lidds AB are associated (or correlated) with Newbury Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Newbury Pharmaceuticals has no effect on the direction of Lidds AB i.e., Lidds AB and Newbury Pharmaceuticals go up and down completely randomly.

Pair Corralation between Lidds AB and Newbury Pharmaceuticals

Assuming the 90 days trading horizon Lidds AB is expected to generate 3.28 times more return on investment than Newbury Pharmaceuticals. However, Lidds AB is 3.28 times more volatile than Newbury Pharmaceuticals AB. It trades about 0.04 of its potential returns per unit of risk. Newbury Pharmaceuticals AB is currently generating about 0.01 per unit of risk. If you would invest  13.00  in Lidds AB on September 4, 2024 and sell it today you would lose (3.00) from holding Lidds AB or give up 23.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Lidds AB  vs.  Newbury Pharmaceuticals AB

 Performance 
       Timeline  
Lidds AB 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Lidds AB are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Lidds AB unveiled solid returns over the last few months and may actually be approaching a breakup point.
Newbury Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Newbury Pharmaceuticals AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Newbury Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Lidds AB and Newbury Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lidds AB and Newbury Pharmaceuticals

The main advantage of trading using opposite Lidds AB and Newbury Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lidds AB position performs unexpectedly, Newbury Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Newbury Pharmaceuticals will offset losses from the drop in Newbury Pharmaceuticals' long position.
The idea behind Lidds AB and Newbury Pharmaceuticals AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences